» Articles » PMID: 18086900

In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-forming Cell Numbers and Function

Overview
Journal Diabetes
Specialty Endocrinology
Date 2007 Dec 19
PMID 18086900
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Emerging data demonstrate that maternal diabetes has long-term health consequences for offspring, including the development of hypertension. In adults, circulating endothelial progenitor cells (EPCs) participate in vascular repair, and EPC numbers and function inversely correlate with the risk of developing vascular disease. Therefore, our objectives were to determine whether hyperglycemia or exposure to a diabetic intrauterine environment alters EPC function.

Research Design And Methods: We used well-established clonogenic endothelial colony-forming cell (ECFC) assays and murine transplantation experiments to examine human vasculogenesis.

Results: Both in vitro hyperglycemia and a diabetic intrauterine environment reduced ECFC colony formation, self-renewal capacity, and capillary-like tube formation in matrigel. This cellular phenotype was linked to premature senescence and reduced proliferation. Further, cord blood ECFCs from diabetic pregnancies formed fewer chimeric vessels de novo after transplantation into immunodeficient mice compared with neonatal ECFCs harvested from uncomplicated pregnancies. CONCLUSIONS; Collectively, these data demonstrate that hyperglycemia or exposure to a diabetic intrauterine environment diminishes neonatal ECFC function both in vitro and in vivo, providing potential mechanistic insights into the long-term cardiovascular complications observed in newborns of diabetic pregnancies.

Citing Articles

Targeting pericyte retention in Diabetic Retinopathy: a review.

Bohler F, Bohler L, Taranikanti V Ann Med. 2024; 56(1):2398200.

PMID: 39268600 PMC: 11404372. DOI: 10.1080/07853890.2024.2398200.


Enhancing endothelial colony-forming cells for treating diabetic vascular complications: challenges and clinical prospects.

Liu Y, Lyons C, Ayu C, OBrien T Front Endocrinol (Lausanne). 2024; 15:1396794.

PMID: 39076517 PMC: 11284052. DOI: 10.3389/fendo.2024.1396794.


Human Cord Blood Endothelial Progenitor Cells and Pregnancy Complications (Preeclampsia, Gestational Diabetes Mellitus, and Fetal Growth Restriction).

Kwon J, Maeng Y Int J Mol Sci. 2024; 25(8).

PMID: 38674031 PMC: 11050478. DOI: 10.3390/ijms25084444.


New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications.

Gallo G, Savoia C Int J Mol Sci. 2024; 25(5).

PMID: 38474219 PMC: 10932073. DOI: 10.3390/ijms25052973.


Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells.

Kulovic-Sissawo A, Tocantins C, Diniz M, Weiss E, Steiner A, Tokic S Biology (Basel). 2024; 13(2).

PMID: 38392289 PMC: 10886154. DOI: 10.3390/biology13020070.